Abstracts

SARS-CoV-2 SEROPREVALENCE TREND AMONG PREGNANT WOMEN IN ZAMBIA, 2021-2022

Background: Confirmed COVID-19 case counts underestimate SARS-CoV-2 infections, particularly in countries with limited testing capacity. Pregnant women attending antenatal care (ANC) clinics have served as healthy population surrogates to monitor diseases like HIV and malaria. We measured SARS-CoV-2 seroprevalence among women attending ANC clinics to assess infection trends over time in Zambia. Methods: We conducted…

MPOX OUTBREAK IN PLWHA AND PrEP USERS IN A BRAZILIAN STI CENTER: DIFFERENT CHALLENGES

Background: Since the beginning of the current MPOX outbreak, reports and case series have highlighted a significant distribution in people living with HIV (PLWHA) and also in pre-exposure prophylaxis (PrEP) users. Despite similar vulnerability behaviors, these populations are distinct from an immunological view. We evaluated the differences in clinical presentation between PLWHA and PrEP users.…

MOLNUPAVIR IN PREVIOUSLY UNINFECTED NONHOSPITALIZED PERSONS WITH COVID-19

Background: Clinical benefit of Molnupiravir (MPV) in COVID-19 infected sub-populations is unclear. Methods: We used a matched cohort design emulating a target trial to analyze the VA COVID-19 Shared Resource database to determine the association of MPV with hospitalization or death within 30 days compared with untreated controls in previously uninfected non-hospitalized persons. Incidence of…

COVID-19 OUTCOME IN PATIENTS WITH AND WITHOUT CIRRHOSIS

Background: Severe outcomes of COVID-19 are associated with advancing age, and multiple medical comorbidities. The impact of COVID-19 on the clinical course of patients with cirrhosis has not been well studied. We determined the effect of SARS-CoV-2 infection on the hospitalization and survival rates of patients with cirrhosis. Methods: Using ICD-10-CM codes, we identified all…